We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

21 hedge funds and large institutions have $1.88M invested in Vaxart in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

24% more funds holding

Funds holding: 17 → 21 (+4)

14% more capital invested

Capital invested by funds: $1.64M → $1.88M (+$234K)

1.62% more ownership

Funds ownership: 7.6% → 9.22% (+1.6%)

Holders
21
Holders Change
+4
Holders Change %
+23.53%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$220K
2
Renaissance Technologies
Renaissance Technologies
New York
+$60.2K
3
Citadel Advisors
Citadel Advisors
Florida
+$38.6K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$33K
5
Bank of America
Bank of America
North Carolina
+$12K

Top Sellers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
-$22.5K
2
Morgan Stanley
Morgan Stanley
New York
-$15
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$667K +$60.2K +19,800 +9%
AC
2
Armistice Capital
New York
$428K +$220K +72,401 +93%
Vanguard Group
3
Vanguard Group
Pennsylvania
$252K +$383 +126 +0.1%
BlackRock
4
BlackRock
New York
$149K +$1.45K +477 +0.9%
CCM
5
Carlson Capital Management
Minnesota
$81K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$61K – – –
GCIA
7
Gabelli & Co Investment Advisers
New York
$54K – – –
PAM
8
Panagora Asset Management
Massachusetts
$46K -$22.5K -7,404 -32%
Citadel Advisors
9
Citadel Advisors
Florida
$36K +$38.6K +12,683 New
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$31K +$33K +10,863 New
RFWA
11
RPg Family Wealth Advisory
Massachusetts
$28.5K – – –
UBS Group
12
UBS Group
Switzerland
$15K +$9.33K +3,068 +143%
Bank of America
13
Bank of America
North Carolina
$11K +$12K +3,943 New
PNC Financial Services Group
14
PNC Financial Services Group
Pennsylvania
$9K – – –
TL
15
TowerView LLC
New York
$5K – – –
Morgan Stanley
16
Morgan Stanley
New York
$2K -$15 -5 -0.7%
RE
17
RBC Europe
United Kingdom
$2K – – –
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
– +$27 +9 New

VXRT Hedge Fund Activity: Q3 2018 in Review

21 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2018, worth a combined $1.88M — up 14% from $1.64M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new VXRT positions and 0 closed out — a net gain of 4 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Armistice Capital, adding an estimated $220K. The largest seller was Panagora Asset Management, cutting an estimated $22.5K.

  • 21 institutional investors held Vaxart (VXRT) as of Q3 2018, up from 17 in Q2 2018.
  • Funds reported $1.88M of Vaxart stock for Q3 2018, up 14% quarter-over-quarter.
  • 4 funds opened new Vaxart positions in Q3 2018 and 0 closed out, a net change of +4 holders.
  • The largest Vaxart buyer in Q3 2018 was Armistice Capital, an estimated $220K added.
  • The largest Vaxart seller in Q3 2018 was Panagora Asset Management, an estimated $22.5K sold.

Based on aggregated 13F filings for Q3 2018.